| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Kim Peter S is a Director at Entrada Therapeutics, Inc.. Recent SEC Form 4 filings include 11 buys and 0 sells.
Estimated insider holdings value: $740K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | TRDA Entrada Therapeutics, Inc. | Director | Buy | 25,000 | $14.59 | $364,672.50 | +37.1% | +0.1% | -43.8% | |
| May 9, 2024 | TRDA Entrada Therapeutics, Inc. | Director | Buy | 4,476 | $14.14 | $63,305.58 | +3.5% | -3.8% | -41.6% | |
| Apr 8, 2024 | TRDA Entrada Therapeutics, Inc. | Director | Buy | 2,600 | $13.57 | $35,289.80 | +4.3% | +12.6% | -43.9% | |
| Mar 28, 2024 | TRDA Entrada Therapeutics, Inc. | Director | Buy | 1,512 | $13.75 | $20,793.93 | +2.6% | -0.5% | -32.5% | |
| Mar 26, 2024 | TRDA Entrada Therapeutics, Inc. | Director | Buy | 9,048 | $13.58 | $122,881.82 | +5.7% | +3.5% | -28.1% | |
| Mar 21, 2024 | TRDA Entrada Therapeutics, Inc. | Director | Buy | 2,732 | $12.81 | $34,995.55 | +1.9% | +6.6% | -22.5% |